Applied Historical Cash Flow
| APLT Stock | USD 9.63 0.36 3.88% |
Analysis of Applied Therapeutics cash flow over time is an excellent tool to project Applied Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Inventory of 0.0 or Investments of 14.6 M as it is a great indicator of Applied Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Applied Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Applied Therapeutics is a good buy for the upcoming year.
Applied |
About Applied Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Applied balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Applied's non-liquid assets can be easily converted into cash.
Applied Therapeutics Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Applied Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Applied Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.At this time, Applied Therapeutics' Investments are comparatively stable compared to the past year. Change In Cash is likely to gain to about 34.9 M in 2024, whereas Stock Based Compensation is likely to drop slightly above 6.7 M in 2024.
Applied Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Applied Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Applied Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 102K | 38.6M | (3.6M) | (37.2M) | 33.2M | 34.9M | |
| Stock Based Compensation | 6.2M | 8.0M | 11.2M | 9.6M | 7.4M | 6.7M | |
| Free Cash Flow | (36.3M) | (78.2M) | (90.7M) | (78.1M) | (55.2M) | (57.9M) | |
| Change In Working Capital | 3.2M | 5.2M | 3.7M | (8.8M) | (1.4M) | (1.4M) | |
| Begin Period Cash Flow | 18.7M | 18.9M | 57.5M | 53.9M | 16.7M | 26.5M | |
| Other Cashflows From Financing Activities | 3.2M | 4.3M | 5.0M | 3.2M | 11.9M | 6.9M | |
| Other Non Cash Items | (218K) | (360K) | (404K) | 3.7M | 58.3M | 61.2M | |
| Total Cash From Operating Activities | (36.3M) | (78.2M) | (90.7M) | (78.1M) | (55.2M) | (57.9M) | |
| Change To Operating Activities | (238K) | (2.5M) | 13.2M | (5.2M) | (5.9M) | (5.6M) | |
| Net Income | (45.5M) | (94.0M) | (105.6M) | (82.5M) | (119.8M) | (113.8M) | |
| Total Cash From Financing Activities | 56.4M | 136.3M | 74.7M | 27.7M | 74.5M | 63.3M | |
| End Period Cash Flow | 18.9M | 57.5M | 53.9M | 16.7M | 49.9M | 34.4M | |
| Change To Netincome | 3.3M | 6.0M | 10.2M | 10.8M | 12.4M | 6.8M | |
| Change To Liabilities | 2.3M | 5.8M | (8.0M) | 8.8M | 10.1M | 10.7M | |
| Issuance Of Capital Stock | 58.7M | 134.1M | 74.4M | 27.8M | 64.5M | 69.8M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Applied Stock Analysis
When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.